different investigation methods on the reported incidence of AMS.
INTRODUCTION
Reports of acute mountain sickness (AMS) at moderate altitude show a wide variability, possibly because of different investigation methods. The aim of our study was to investigate the impact of investigation methods on AMS incidence. Hackett's established AMS score (a structured interview and physical examination), the new Lake Louise AMS score (a self-reported questionnaire) and oxygen saturation were determined in 99 alpinists after ascent to 2.94 km altitude. AMS incidence was 8% in Hackett's AMS score and 25% in the Lake Louise AMS score. Oxygen saturation correlated inversely with Hackett's AMS score with no significant correlation with the Lake Louise AMS score. At moderate altitude, the new Lake Louise AMS score overestimates AMS incidence considerably. Hackett's AMS score remains the gold standard for evaluating AMS incidence.
How can acute mountain sickness be quantified at moderate altitude?
Lowland dwellers who rapidly ascend to high altitude may develop one or more unpleasant symptoms such as headache, anorexia, and insomnia. If several of these symptoms, which may progressively include vomiting, shortness of breath, severe headache, and ataxia, are present,~he syndrome is de~ned.
as acute mo~tain sickness (~MS).
Physical examination of these patients may disclote tachypnoea, pulmonary rales, and periorbital as well as peripheral oedema.
The incidence of AMS was first reported in 1976; Hackett and colleagues found 53% of 278 unacclimatized hikers to suffer from AMS at 4.173 km altitude in the Himalayas of Nepal'. Various studies found similar results at high altitude. The situation at moderate altitude is not yet clear. Two European studies based on Hackett's established AMS-score (a scoring system consisting of a structured interview and physical examination by an experienced investigator) report an AMS incidence of 3. 1% at 1.98 km to 9% at 2.82 km 1 ,3, whereas an American study based on the new Lake Louise consensus document on definition and quantification of AMS, which determines the incidence of AMS on a self-reported questionnaire", reports an AMS incidence of 25% at 1.89-2.91 km s. This variability could be related to the different investigation instruments used". The aim of our study was to investigate the impact of the Table4 Arterial oxygen saturation in the total alpinist population and in the subgroups with signs and symptoms of acute mountain sickness lAMS) at 2.94 km altitude
AMS signlsympton
No Yes 
82-96
Total alpinist population
Hackett-AMS score 1-2 Lake Louise-AMS score 1-2
Hackett-AMS score~3
Lake Louise-AMS score~3
RESULTS
symptom of AMS were considered healthy, those with one or two score points were considered to be moderately affected, and those with three or more score points were regarded as suffering from AMS. Not all the alpinists had slept at altitude, so sleep disturbance was not recorded in either test. Age, gender, medical history, individual history of AMS, smoker or non-smoker, altitude of home residence and number of alpine tours per year were noted.
Statistical methods
Spearman rank correlation and Mann-Whitney-rank-sumtest. P<0.05 was considered significant.
Ninety-nine alpinists volunteered to participate: 70 men and 29 women (age range 18-66, mean age 35.4± 13.8; 23 smokers; no subject had a medical or AMS-history; no subject took any medication; subjects had made 9.0 ±3.4 alpine tours per year; all subjects had a home residence below 0.9 km altitude); and they were examined in similar weather conditions between 1100 hand 1300 h. Hackett's AMS scores and Lake Louise AMS scores correlated significantly (n=99, r=0.846, P<O.OI), but Hackett's AMS scores were significantly lower (P<O.OI), AMSincidence with Hackett's score was lower and the number of unaffected alpinists higher than with the Lake Louise-AMS questionnaire (Table 1) . The most common AMS-signs and symptoms in the Hackett AMS-score were dizziness followed by tachypnoea and headache; the most common AMS symptoms in the Lake Louise-AMS questionnaire were fatigue followed by dizziness and shortness of breath (Tables  2 and 3) . Results within the respective AMS Scores did not differ according to the order of the evaluating instruments. Arterial oxygen saturation in subjects with an AMS score~1 correlated inversely with Hackett's AMS score (n =27, r= -0.478, P<0.05) with no significant correlation to the Lake Louis AMS score (n=49, r= -0.148, P=NS).
Oxygen saturation of all mountaineers is listed in Table 4 .
Smoking habit, age, gender and number of alpine tours per year did not differ in alpinists with and without signs and symptoms. of AMS.
DISCUSSION
Scientific research in alpine medicine has dealt primarily with small groups of healthy athletic persons at above 4 km altitude, even though most mountain tours are at moderate altitude (i.e. 2-4 km) and most mountaineers are not trained athletes. Lately more emphasis has been put on a general tourist population at moderate altitudes. For many years Hackett's AMS score was the only established method of evaluating altitude adaptation disorder. Leading experts on altitude medicine have recently inroduced a new self reporting system of evaluating AMS in the Lake Louise consensus document on definition and quantification of AMS. The aim of our study was to validate both methods by comparison. In our study, AMS incidence by Hackett's AMS score was 8% at 2.94km altitude. This corresponds very well to previous reports of AMS incidence at moderate altitude from the Swiss and Austrian Alps. AMS-incidence in the same alpinists in the same situation by the Lake Louise AMS score was 25%. A periodic effect (an effect of observation time on altitude adaptation) was ruled out by examining all subjects at stable conditions after 30 min rest and performing both AMS evaluating methods within 10 min, and, as the sequence of tests had no influence on the results, periodic effects as well as carry-over effects between both tests were unlikely. The main reason for the higher Lake Louise AMSscores was the predominance of the symptom 'unusual fatigue', which is clearly difficult to differentiate from usual fatigue after many hours of strenuous ascent. The symptom dizziness was reported twice as often in the Lake Louise questionnaire. The high incidence of shortness of breath in the Lake Louise questionnaire did not correspond to an equivalent" incidence of tachypnoea or pulmonary rales in Hackett's < ,*,MS score. Physicians are obviously more competent than alpinists by themselves in discriminating non-specific symptoms, which are mainly due to exhaustion, from directly AMS related signs and symptoms. Clinically, no alpinist suffered a severe form of AMS (i.e. high altitude pulmonary oedema or high altitude cerebral oedema). Lake Louise AMS score was~3 in all alpinists with a Hackett AMS score of~3. Oxygen saturation in patients with high altitude adaptation disorders is known to correlate inversely with AMS score 7 . This holds true for Hackett's AMS score in our study; no correlation with the Lake Louise AMS score was found.
The main finding of our study is that the new Lake Louise AMS score considerablv overestimates the AMS / incidence at moderate altitude. The importance of the new score is in our opinion in the easy self rating of possible high altitude adaptation disorders by alpinists. However, Hackett's AMS-score remains the gold standard for evaluating AMS incidence.
